Zacks Investment Research cut shares of Kindred Healthcare, Inc. (NYSE:KND) from a hold rating to a sell rating in a research report report published on Wednesday morning.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

Other research analysts have also recently issued reports about the stock. Deutsche Bank AG reissued a hold rating and set a $9.00 price target (down from $10.00) on shares of Kindred Healthcare in a report on Monday, September 18th. BidaskClub cut shares of Kindred Healthcare from a buy rating to a hold rating in a report on Wednesday, July 12th. Mizuho reissued a neutral rating and set a $9.00 price target on shares of Kindred Healthcare in a report on Monday, July 3rd. Royal Bank Of Canada cut their price target on shares of Kindred Healthcare from $9.00 to $7.50 and set a sector perform rating for the company in a report on Thursday, September 21st. Finally, Bank of America Corporation cut their price target on shares of Kindred Healthcare from $7.50 to $6.50 and set an underperform rating for the company in a report on Thursday, September 21st. Six investment analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of $8.94.

Shares of Kindred Healthcare (NYSE KND) opened at 6.50 on Wednesday. The firm’s market capitalization is $565.62 million. The stock’s 50 day moving average price is $7.17 and its 200-day moving average price is $9.05. Kindred Healthcare has a 52-week low of $5.50 and a 52-week high of $11.90.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The firm’s revenue for the quarter was down 4.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.38 earnings per share. Equities research analysts anticipate that Kindred Healthcare will post $0.32 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.watchlistnews.com/kindred-healthcare-inc-knd-cut-to-sell-at-zacks-investment-research-2/1615273.html.

A number of institutional investors have recently modified their holdings of KND. SG Americas Securities LLC grew its position in shares of Kindred Healthcare by 28.1% in the first quarter. SG Americas Securities LLC now owns 20,915 shares of the health services provider’s stock valued at $175,000 after purchasing an additional 4,584 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of Kindred Healthcare by 149.4% in the second quarter. JPMorgan Chase & Co. now owns 2,104,618 shares of the health services provider’s stock valued at $24,518,000 after purchasing an additional 1,260,753 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Kindred Healthcare by 2.4% in the second quarter. Bank of New York Mellon Corp now owns 1,488,869 shares of the health services provider’s stock valued at $17,345,000 after purchasing an additional 34,553 shares during the last quarter. Point72 Asia Hong Kong Ltd acquired a new stake in shares of Kindred Healthcare in the first quarter valued at approximately $121,000. Finally, Goldman Sachs Group Inc. grew its position in shares of Kindred Healthcare by 2.6% in the first quarter. Goldman Sachs Group Inc. now owns 866,881 shares of the health services provider’s stock valued at $7,239,000 after purchasing an additional 22,210 shares during the last quarter. 88.14% of the stock is owned by institutional investors.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.